1204142-66-4

Upstream product

• 1204142-65-3 2-{4-[(4-methoxy-phenyl)methylamino]quinazolin-2-ylmethyl}isoindole-1,3-dione 
• 1204142-63-1 4-[(4-methoxyphenyl)(methy)amino]quinazoline-2-carbonitrile 

Downstream Products

• 1216817-52-5 [(S)-1-({4-[(4-methoxy-phenyl)methylamino]quinazolin-2-ylmethyl}carbamoyl)-ethyl]-carbamic acid tert-butyl ester 
• 1217306-52-9 {4-[(4-methoxy-phenyl)methylamino]quinazolin-2-ylmethyl}carbamic acid 1-chloro-ethyl ester 
• 1217306-50-7 (2-aminomethyl-quinazolin-4-yl)-(4-methoxy-phenyl)methylamine hydrogen sulfate 
• 1217306-38-1 acetic acid 3-acetoxy-2-{4-[(4-methoxy-phenyl)methylamino]quinazolin-2-ylmethylcarbamoyloxy}propyl ester 
• 1312335-57-1 C₂₅H₂₈N₄O₇ 

Relevant academic research and scientific papers

PHARMACEUTICAL COMPOUNDS AS INHIBITORS OF CELL PROLIFERATION AND THE USE THEREOF

Disclosed are compounds of Formula I effective as cytotoxic agents. The compounds of this invention are useful in the treatment of a variety of clinical conditions in which uncontrolled growth and spread of abnormal cells occurs.

PHARMACEUTICAL COMPOUNDS AS CYTOTOXIC AGENTS AND THE USE THEREOF

Disclosed are compounds effective as cytotoxic agents. The compounds of this invention are useful in the treatment of a variety of clinical conditions in which uncontrolled growth and spread of abnormal cells occurs.